DoseDr Telemedicine Platform Expanded for Use Treating All Chronic Diseases

Telemedicine provider DoseDr announced today its platform now supports treatment for all chronic disease—hypertension and related conditions including coronary artery disease, chronic kidney disease, stroke, and essential hypertension—tackling the problems currently unaddressed by the health care industry.

The Centers for Disease Control and Prevention (CDC) reports that 86 percent of the $2.7 trillion spent annually on health care goes toward chronic disease, more than half to cover costs associated with exacerbations and preventable complications.

Realizing the motivation exists on both sides—patients want to take better care of themselves and doctors what to help them to do so—DoseDr was determined to close the gap by finally providing the tools needed to fix what’s broken with the health care system and save trillions of dollars in the process.

For the past two years, DoseDr has worked to tackle the diabetes problem, achieving unprecedented results. A recently published pilot study conducted at the 281-CHRISTUS St. Frances Cabrini Hospital found that using DoseDr reduced average A1c levels from 9.6 to 6.3 in three months, a feat that normally takes years. Patient adherence to multiple-times-a-day glucose checks and insulin injections reached 88 percent and, of the 14,460 clicks in the first three months of the pilot, just one was symptomatic hypoglycemia – a patient injected insulin without eating. The resulting hypoglycemia was corrected by the DoseDr app without any other intervention.

“DoseDr addresses the problems the current health care system can’t. Most patients get only two and a half hours with their doctor per year, so the reality is that chronic diseases are mostly treated by the patient,” said DoseDr Co-founder and Chief Medical Officer Dustyn Williams, M.D. “The rest of the time it is up to patients and caretakers to manage these conditions, which is notoriously difficult in the case of chronic disease. Multiple medications, including those like insulin where dosing is complex and may change from one day to the next, and an endless barrage of daily requirements exacerbates the problem.”

To learn more, click here.

This post was written by:

- who has written 2292 posts on mHealthWatch.

Contact the author